alkenes has been researched along with phenyl-n-tert-butylnitrone in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Albores, A; Eldirdiri, NI; Ferrara, R; King, LJ; Manno, M; Tolando, R | 1 |
Bacskai, BJ; Betensky, R; Borrelli, LA; Fine, S; Frosch, MP; Garcia-Alloza, M; Greenberg, SM; Lattarulo, C; Prada, C | 1 |
2 other study(ies) available for alkenes and phenyl-n-tert-butylnitrone
Article | Year |
---|---|
Reductive activation of 1,1-dichloro-1-fluoroethane (HCFC-141b) by phenobarbital- and pyridine-induced rat liver microsomal cytochrome P450.
Topics: Alkenes; Anaerobiosis; Animals; Biotransformation; Carbon Monoxide; Chlorofluorocarbons; Chlorofluorocarbons, Ethane; Cyclic N-Oxides; Cytochrome P-450 CYP2B1; Cytochrome P-450 CYP2E1; Cytochrome P-450 Enzyme System; Glutathione; Heme; Male; Microsomes, Liver; NADP; Nitrogen Oxides; Oxidation-Reduction; Phenobarbital; Pyridines; Rats; Rats, Wistar | 1996 |
Matrix metalloproteinase inhibition reduces oxidative stress associated with cerebral amyloid angiopathy in vivo in transgenic mice.
Topics: Alkenes; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Benzene Derivatives; Cerebral Amyloid Angiopathy; Cyclic N-Oxides; Dipeptides; Fluorescent Dyes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Mice; Mice, Transgenic; Minocycline; Oxidative Stress; Presenilin-1; Protease Inhibitors; Reactive Oxygen Species; Simvastatin; Statistics as Topic; Stilbenes; Time Factors | 2009 |